Meridian Medical Technologies, a Kindeva Drug Delivery Company, a leading global contract development and manufacturing organization (CDMO) focused on drug-device combination products, announced today, during National Community Development Week, it will expand manufacturing capabilities in Bridgeton, Missouri — investing more than $100 million over the next four years in a newly purchased facility. 

Meridian, which recently combined with Kindeva, will be converting this new 155,000-square-foot facility to support increased production of drug-device combination products, sterile fill-finish capabilities, and create job opportunities in the St Louis area. 

“We’re proud to have a leading, high-tech manufacturer like Meridian Medical Technologies expanding in St. Louis,” said Gov. Mike Parson. “It’s always exciting to see a local employer thriving, creating jobs, and developing innovative products right here in our state. We wish Meridian the best and look forward to its future growth as it continues to succeed in the region.”

Meridian founded the autoinjector technology and has been a leading manufacturer of emergency autoinjector for more than 60 years. Now with Kindeva, the combined company has a broader range of drug delivery capabilities that this Bridgeton facility investment will help support worldwide.

“Meridian brings a strong history of specific expertise to support critical manufacturing capabilities for complex products — addressing a manufacturing shortage we have seen an increase over the last several years,” said Milton Boyer, Meridian CEO. “Building a broader platform with the latest technologies and equipment available, coupled with enhanced capabilities in the production of pre-filled syringes and cartridges, will enable Meridian to offer a broader array of CDMO services and increased capacity to our customers.”

For this expansion, Meridian will benefit from the Missouri Works program, a tool that helps companies expand and retain workers by providing access to capital through withholdings or tax credits for job creation.